Congratulations to Dr. Rupesh Kotecha and our #RadOnc team at @miamicancerinst for the newly published study highlighting outcomes for patients with large brain metastasis treated with SRS, FSRS, and surgery in the Journal of Neuro-Oncology Journal of Neuro-Oncology ➡️ bapth.lt/3KxWwS7

So proud of the #RadOnc team improving PT outcomes and transforming the standard of care!🍍👏 #ASTRO24 📸 Michael Chuong Kathryn Mittauer, PhD Sreenija Yarlagadda eyub akdemir ASTRO

🍍👏 Dr. Minesh Mehta presents outstanding global reirradiation evidence for LMICs at #ASTRO24 💡 Successful case studies have demonstrated effective application in resource-limited settings.

Glad to make it to #ASTRO24 👉🏻 ML model trained robustly on our institutional dataset of 1503 small BM treated with SRS 👉🏻Predicted % risk of LF as a function of dose with 83% accuracy 👉🏻Suggests individualized best dose Rupesh Kotecha Miami Cancer Institute Research Baptist Health Cancer Care

Delighted to present at #ASTRO24 👉🏻Objective taste testing done on patients receiving head and neck RT 👉🏻Characterized trends of dysgeusia during RT and follow up 👉🏻 Noted significant correlation with tongue dose Miami Cancer Institute Research

Rupesh Kotecha, MD, (Rupesh Kotecha) discussed a machine learning tool designed to predict local failure after stereotactic radiosurgery for brain metastases. #ASTRO24 | Miami Cancer Institute Research Baptist Health Cancer Care Baptist Health targetedonc.com/view/machine-l…

Rupesh Kotecha Sreenija Yarlagadda Reshma Mahtani Manmeet Ahluwalia, MD, MBA, FASCO Sasha Beyer Joshua D. Palmer, MD Rituraj Upadhyay, MD Nicole Williams MD Kamran Ahmed Matthew Mills Daniel (Donny) Oliver JM Bryant, MD Justyn Nakashima, DO Dekuang Zhao Ajay Doniparthi

Is concurrent Trastuzumab-deruxtecan (T-DXd) & SRS for brain mets safe? According to this study Yes -215 mets -Cumulative incidence symptomatic RN 2% at2yr -1 Yr LC 97% rdcu.be/d5reQ

Our Miami Cancer Institute Research MR-Linac program began in 2018 as one of the first in the world. Here's an overview of our pt triage & treatment patterns in the context of offering many other advanced #radonc platforms. Online adaptive times can be feasible! mdpi.com/2072-6694/17/2…

From the #RedJournal by eyub akdemir, Rupesh Kotecha, Miami Cancer Institute Research et al, read about Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Infradiaphragmatic Oligometastatic Disease: Disrupting the One-Size-Fits-All Paradigm: tinyurl.com/kotechared

🚨 Placebo Controlled Randomized Trial: Memantine given w/Brain RT Improved Cognitive Outcomes & QOL 🚨🚨🚨

Honored to share our latest publication in Cancers MDPI Connectome analysis reveal WBRT-induced alterations correlating with cognitive decline mdpi.com/2072-6694/17/1… Big thanks to our brilliant team Rupesh Kotecha Tugce Kutuk, MD, MS Miami Cancer Institute Research #Connectmics #Neuroscience

Our new paper in Journal of Neuro-Oncology Analyzed >1500 brain mets treated with SRS & built ML models to predict LF at 6m-2yrs & recommend best individualized dose 🔗 link.springer.com/article/10.100… Miami Cancer Institute Research #RadOnc #AIinMedicine #BrainMets #NeuroOncology #OncoDaily

Dr. Sreenija Yarlagadda presents Normal Tissue Complication Probability Model Predicting the Risk of Radiation Necrosis after Stereotactic Radiosurgery for Small Brain Metastases. #ASTRO25 ASTRO

Sreenija Yarlagadda presents A Deep Quantitative Assessment of Metabolic Mucosal Changes with Variable Relative Biological Effectiveness of Head and Neck Proton Therapy. #ASTRO25 ASTRO

Excellent physics #ASTRO25 session happening now “imaging biomarker for response monitoring”. 2 great H/N talks: ✅ADC on MR Linac for HPV- oropharyngeal predicting LEF by Brigid McDonald ✅ Sreenija Yarlagadda showed correlation of SUV uptake post proton therapy and LET/RBE in H/N

3rd ASTRO, 3 presentations today, and 300% excited! 2 down, 1 more to go🤩 #ASTRO25 ASTRO Miami Cancer Institute Research

Highlights from today at #ASTRO25 included research from Dr. Chaswal on tile estimation workflows and Dr. Yarlagadda on NTCP modeling, biomarkers, and lymphopenia. ASTRO

Such an amazing experience at #ASTRO25! Grateful for the opportunity to learn from inspiring talks, share my work and connect with brilliant minds that push our field forward. Very proud to be a part of such a great team at Baptist Health Cancer Care Miami Cancer Institute Research ASTRO